期刊文献+

再生障碍性贫血临床实践指南研究现状及中医指南的修订与思考 被引量:16

Research Status of Clinical Practice Guidelines for Aplastic Anemia and Amendment and Thinking of TCM Guidelines
原文传递
导出
摘要 再生障碍性贫血(简称再障)经过100多年的认知和临床实践,治疗水平得到飞速发展。随着中医诊疗水平的发展以及中医药规范化工作的推进,建立和优化再障中医诊疗指南具有特殊的意义。回顾了国内外近20年再障临床实践指南的现状,分析了各指南形成的背景、特点及差异,结合目前再障中医诊疗指南/共识的特点,论述了中医指南修订的价值、特点和可以借鉴的方法。 After 100 years of knowledge and clinical practice, the treatment of aplastic anemia has rapidly developed. With the development of TCM diagnosis and treatment and promotion of TCM standardization, the establishment and optimization of TCM diagnosis and treatment guidelines for aplastic anemia have special significance. The current status of clinical practice guidelines for aplastic anemia in the past 20 years was reviewed and the formation back- ground, characteristics and differences of various guidelines were analyzed. The value, characteristics and methods of TCM guidelines amendment were discussed according to status of TCM clinical research and the characteristics of TCM diagnosis and treatment guidelines for aplastic anemia.
出处 《中医杂志》 CSCD 北大核心 2014年第4期274-278,共5页 Journal of Traditional Chinese Medicine
基金 国家中医药管理局中医药行业科研专项资助项目(201107001) 国家中医临床研究基地业务建设科研专项资助项目(JDZX2012172)
关键词 再生障碍性贫血 髓劳 临床实践指南 中医 aplastic anemia marrow consumption clinical practice guidelines Chinese medicine
  • 相关文献

参考文献22

  • 1Dufour C, Svahn J, Bacigalupo A, et al. Front-line immu- nosuppressive treatment of acquired aplastic anemia [ J ]. Bone Marrow Transplant, 2013,48 (2) : 174 - 177.
  • 2Kikuchi A, Yabe H, Kato K, et al. Long-term outcome of childhood aplastic anemia patients who underwent allogene- ic hematopoietic SCT from an HLA-matched sibling donor in Japan [ J ]. Bone Marrow Transplant, 2013,48 (5) : 657 - 660.
  • 3夏乐三.近年来国内对再生障碍性贫血的研究概况.中级医刊,1964,3:169-172.
  • 4Bacigalupo A. Guidelines for the treatment of severe aplas- tic anemia. Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Trans- plantation (EBMT) [ J ]. Haematologica, 1994,79 ( 5 ) : 438 - 444.
  • 5Guidelines on the provision of facilities for the care of adult patients with haematological malignancies (including leu- kaemia and lymphoma and severe bone marrow failure). British Committee for Standards in Haematology Clinical Haematology Task Force [ J]. Clin Lab Haematol, 1995, 17(1):3-10.
  • 6Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia [J]. BrJHaematol, 2003,123(5):782-801.
  • 7Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the ~tiagnosis and management of aplastic anaemia [ J ]. Br J Haematol, 2009,147( 1 ) :43 -70.
  • 8Judith Marsh, Jamie Cavanagh, Phil Darbyshire, et al. Guidance from the BCSH Aplastic Anaemia Writing Com- mittee relating to recent prospective studies of rabbit anti- thymocyte globulin (ATG) used for a first course of immu- nosuppressive therapy (IST) in aplastic anaemia [ EB/ OL ]. [ 2011 - 07 ]. http ://www. bcshguidelines, com.
  • 9Kojima S, Nakao S, Tomonaga M, et al. Consensus con- ference on the treatment of aplastic anemia [ J ]. Int J Hematol, 2000,72 ( 1 ) : 118 - 123.
  • 10Sugihara T. Treatment guideline for aplastic anemia and the actual status of its applications [ J ]. Nihon Naika Gakkai Zasshi, 2008,97 (7) : 1698 - 1705.

二级参考文献34

  • 1肝纤维化中西医结合诊疗指南[J].中国中西医结合杂志,2006,26(11):1052-1056. 被引量:47
  • 2中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].药品评价,2007,4(2):74-76. 被引量:26
  • 3Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the diagno- sis and management of aplastic anaemia. Br J Haematol,2009, 147:43-70.
  • 4Scheinberg P, Nunez O, Wu C,et al. Treatment of severe aplastic anaemia with combined immunosuppression: antithymocyte globu- lin, cyclosporin and mycophenolate mofetil. Br J Haematol,2006, 133,606-611.
  • 5Scheinberg Ph, Wu CO, Nunez O, et al. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimas : a prospective random- ized study. Haematologica ,2009,94:348-354.
  • 6Atta EH, Dias DS, Marra VL, et al. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.Ann Hematol, 2010,89:851 -859.
  • 7Baumann H, Judith D, Zey C, et al. Antithymocyte globulin Fre- senius or San gstat (Genzyme) as part of the conditioning for unre- lated donor HSCT: emerging differences in posttransplant immune reconstitution. BMT,2004, 33:S51.
  • 8Terasako K, Sato K, Sato M, et al. The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. Hematology, 2010,15 : 165-169.
  • 9Ducloux D, Kazory A, Challier B, et al. Long-term toxicity of an- tithymocyte globulin induction may vary with choice of agent : a sin- gle-center retrospective study. Transplantation, 2004, 77: 1029- 1033.
  • 10Calistri E, Tiribelli M, Battista M, et al. Epstein-Barr virus reac- tivation in a patient treated with antithymoeyte globulin for severe aplastic anemia. Am J Hematol, 2006,81:355-357.

共引文献274

同被引文献199

引证文献16

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部